Advisornet Financial’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-250
Closed -$12K 1860
2020
Q3
$12K Sell
250
-2,240
-90% -$76.9K ﹤0.01% 1234
2020
Q2
$90K Sell
2,490
-2,080
-46% -$76.6K 0.01% 699
2020
Q1
$162K Buy
4,570
+3,520
+335% +$144K 0.01% 506
2019
Q4
$48K Buy
1,050
+750
+250% +$27.3K ﹤0.01% 913
2019
Q3
$7K Buy
+300
New +$7.52K ﹤0.01% 1473

Other funds holding ZYME

Advisornet Financial's ZYME Position: Q4 2020 in Review

Advisornet Financial sold out of Zymeworks (ZYME) in Q4 2020, closing a stake of 250 shares — an estimated $12K sold.

Advisornet Financial first reported a position in ZYME in Q3 2019 and held it in 5 quarters. The position peaked at $162K in Q1 2020. 138 funds tracked by Wall St. Rank hold ZYME as of Q4 2020.

  • Advisornet Financial reported no remaining Zymeworks position as of Q4 2020 after selling out during the quarter.
  • Advisornet Financial sold 250 Zymeworks shares in Q4 2020, an estimated $12K.
  • Advisornet Financial first reported a position in Zymeworks in Q3 2019 and held it in 5 quarters.
  • Advisornet Financial's Zymeworks position peaked at $162K in Q1 2020.
  • 138 funds tracked by Wall St. Rank held Zymeworks as of Q4 2020.

Based on Advisornet Financial's 13F filing for Q4 2020, filed 4 Feb 2021.